Your shopping cart is currently empty

SOS1-IN-25 is an inhibitor of SOS1 that demonstrates inhibitory activity against the formation of the KRASG12C/SOS1 complex, with an IC50 value of 11.11 nM. It also causes a dose-dependent reduction in pERK levels. SOS1-IN-25 can be utilized in leukemia research.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | SOS1-IN-25 is an inhibitor of SOS1 that demonstrates inhibitory activity against the formation of the KRASG12C/SOS1 complex, with an IC50 value of 11.11 nM. It also causes a dose-dependent reduction in pERK levels. SOS1-IN-25 can be utilized in leukemia research. |
| Targets&IC50 | SOS1:11.11 nM |
| In vitro | SOS1-IN-25 (Compound B5a) demonstrates effective anti-proliferative activity against K562 cells with an IC 50 of 1.99 μM over 72 hours. Additionally, SOS1-IN-25, when applied at concentrations ranging from 0 to 300 nM for 2 hours, results in a dose-dependent reduction in pERK levels in K562 cells. |
| Molecular Weight | 519.71 |
| Formula | C29H37N5O2S |
| Cas No. | 3092446-09-5 |
| Smiles | N([C@H](C)C1=CC(=CS1)C2=C(CNC)C=CC=C2)C3=C4C(C(C)(C)C(=O)N(C4)C5CCOCC5)=NC(C)=N3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.